Our Research

IREN Limited

IREN · NASDAQ

Bitcoin Miner-Turned-Neocloud at a $17B Inflection

IREN has structurally re-rated from a Bitcoin miner into a credible Tier-2 AI neocloud, anchored by a $9.7B Microsoft GB300 contract and 4.5 GW of secured low-cost renewable power; only about 10% of that power is contracted so far, which is what makes the setup asymmetric. We rate IREN Bullish, with a $77 base price target over a 12–24 month horizon.

Eli Lilly

LLY · NYSE

GLP-1 Leadership, Oral Expansion & Pipeline Momentum

Eli Lilly is the clear leader in the high-growth GLP-1/GIP cardiometabolic market, backed by superior product efficacy, the first unrestricted oral GLP-1 (Foundayo/orforglipron), and a deep pipeline that includes retatrutide. Consensus price targets imply about 28% upside; we rate LLY Bullish over a 12–24 month horizon.

Micron Technology

MU · NASDAQ

Memory Supercycle: HBM & AI Data Center Demand

Micron is riding a cyclical memory upswing driven by hyperscale cloud spending and AI workloads: HBM industry revenue is expected to nearly double to $34B in 2025, and data center now makes up over 50% of total revenue. FY2025 revenue grew 49% to $37.38B, and analyst consensus is strongly bullish.

Identifying Rising Industries

Using Annual Consulting-Firm Research to Narrow Sector Focus

McKinsey, BCG, and peer consulting firms release deep structural research for free every year, and most investors never open it. This note lays out a process for using those publications to narrow sector focus early, checks how three past themes actually played out at the single-name and ETF level, and extends the numbers to today (July 16, 2026), where the semiconductor and tech funds that lagged early ended up beating the index once the theme had time to price.

Novo Nordisk

NVO · NYSE

GLP-1 Leader Facing Legal & Competitive Headwinds

Novo Nordisk is still the market leader in GLP-1 therapies, though it's facing intensifying competition from Eli Lilly, mounting GLP-1 litigation (MDL 3094), and bearish technical momentum. A weekly close below $68 would confirm sellers in control, with downside targets at $63.13 and $57.00.